histarmar

Asian stocks turned in a mixed performance on Monday amid interest rate uncertainty and concerns over a possible government shutdown in the U.S. The dollar and Treasuries gained ahead of

The September-quarter (second quarter of financial year 2023-24, or Q2FY24) performance of Divi’s Laboratories fell short of analyst expectations, especially on the profitability metric. Rise in input costs, inventory write-off,

After coming under pressure in the latter half of the previous session, stocks may move back to the upside in early trading on Friday. The major index futures are currently

British drug major AstraZeneca Plc. (AZN.L,AZN) announced Friday that the U.S. Food and Drug Administration or FDA has approved its Truqap (capivasertib) in combination with Faslodex (fulvestrant) to treat patients

Asian stocks declined on Friday as a jump in U.S. bond yields following a disappointing Treasury auction coupled with Fed Chair Jerome Powell’s cautious comments on the rate hike path

With mortgage rates approaching 8 percent earlier this month, the National Association of Home Builders released a report on Thursday unexpectedly showing a continued deterioration in U.S. homebuilder confidence in